ClinicalTrials.gov
public full text
Public Domain
IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome
The study will be conducted at 15-20 US centers in a randomized, placebo-controlled, double-blind fashion. Enrollees will be hospitalized sickle cell disease (SCD) patients at-risk for acute chest syndrome (ACS) based on the presence of vaso-occlusive crisis (VOC), fever (T ≥38.0°C) and serum sPLA2 concentration ≥50 ng/mL.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- sPLA2 in EBC During Acute Chest Syndrome#993509
- sPLA2 Inhibition to Decrease Enzyme Release After PCI Trial#801397
- STUMBL vs TTSS in Predicting Morbidity and Mortality of Blunt Chest Trauma#981390
- Comparison of Phenprocoumon and Acetylsalicylic Acid (ASA)#892524
- Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart Disease#882194
Record · ID 827735
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive